相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy
Tong-Young Lee et al.
CLINICAL CANCER RESEARCH (2008)
A quantitative method for measuring the antitumor potency of recombinant human endostatin in vivo
Ye-Fen Xu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
T Bachelot et al.
BRITISH JOURNAL OF CANCER (2006)
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer
AHG Hansma et al.
ANNALS OF ONCOLOGY (2005)
Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells
YS Wang et al.
CURRENT EYE RESEARCH (2005)
Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo
DK Skovseth et al.
BLOOD (2005)
Endostatin: The logic of antiangiogenic therapy
A Abdollahi et al.
DRUG RESISTANCE UPDATES (2005)
Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys
HF Song et al.
ACTA PHARMACOLOGICA SINICA (2005)
Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice
Q Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors
DW Davis et al.
CLINICAL CANCER RESEARCH (2004)
Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors
JP Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily
JP Eder et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phase I study of recombinant human endostatin in patients with advanced solid tumors
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis
GY Yin et al.
MOLECULAR THERAPY (2002)
Generation and degradation of human endostatin proteins by various proteinases
M Ferreras et al.
FEBS LETTERS (2000)
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
YQ Wei et al.
NATURE MEDICINE (2000)
Angiostatin and Endostatin: Endogenous inhibitors of tumor growth
BKL Sim et al.
CANCER AND METASTASIS REVIEWS (2000)
分享论文
